Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Graham

Showing results (1241-1250 of 1,460) with videos related to

Pageof 146
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Science Translational Medicine|November 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trialEsper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.
The Journal of Infectious Diseases|August 15, 2018
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory IllnessNatalie I Mazur, Nicole M Horsley, Janet A Englund, et al.
Nature Communications|February 9, 2020
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responsesSeyhan Boyoglu-Barnum, Geoffrey B Hutchinson, Jeffrey C Boyington, et al.
Med (New York, N.Y.)|September 15, 2022
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatmentJasmin Sponagel, Jill K Jones, Cheryl Frankfater, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
Frontiers in Immunology|December 27, 2021
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah VaccineRebecca J Loomis, Anthony T DiPiazza, Samantha Falcone, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
The Lancet. Public Health|April 15, 2021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological studyMark S Graham, Carole H Sudre, Anna May, et al.
Cell|December 3, 2019
High-Throughput Mapping of B Cell Receptor Sequences to Antigen SpecificityIan Setliff, Andrea R Shiakolas, Kelsey A Pilewski, et al.
Pageof 146

Showing results (1241-1250 of 1,460) with videos related to

Sort By:
Pageof 146
Journal of Immunology (Baltimore, Md. : 1950)|August 5, 2006
Subunit recombinant vaccine protects against monkeypoxJean-Michel Heraud, Yvette Edghill-Smith, Victor Ayala, et al.
Science Translational Medicine|November 22, 2019
Antigenic competition in CD4<sup>+</sup> T cell responses in a randomized, multicenter, double-blind clinical HIV vaccine trialEsper G Kallas, Nicole A Grunenberg, Chenchen Yu, et al.
The Journal of Infectious Diseases|August 15, 2018
Breast Milk Prefusion F Immunoglobulin G as a Correlate of Protection Against Respiratory Syncytial Virus Acute Respiratory IllnessNatalie I Mazur, Nicole M Horsley, Janet A Englund, et al.
Nature Communications|February 9, 2020
Glycan repositioning of influenza hemagglutinin stem facilitates the elicitation of protective cross-group antibody responsesSeyhan Boyoglu-Barnum, Geoffrey B Hutchinson, Jeffrey C Boyington, et al.
Med (New York, N.Y.)|September 15, 2022
Sex differences in brain tumor glutamine metabolism reveal sex-specific vulnerabilities to treatmentJasmin Sponagel, Jill K Jones, Cheryl Frankfater, et al.
The Journal of Infectious Diseases|November 17, 2006
Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 candidate vaccine delivered by a replication-defective recombinant adenovirus vectorAndrew T Catanzaro, Richard A Koup, Mario Roederer, et al.
Frontiers in Immunology|December 27, 2021
Chimeric Fusion (F) and Attachment (G) Glycoprotein Antigen Delivery by mRNA as a Candidate Nipah VaccineRebecca J Loomis, Anthony T DiPiazza, Samantha Falcone, et al.
The Journal of Infectious Diseases|January 15, 2008
A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trialJulie E Martin, Theodore C Pierson, Sarah Hubka, et al.
The Lancet. Public Health|April 15, 2021
Changes in symptomatology, reinfection, and transmissibility associated with the SARS-CoV-2 variant B.1.1.7: an ecological studyMark S Graham, Carole H Sudre, Anna May, et al.
Cell|December 3, 2019
High-Throughput Mapping of B Cell Receptor Sequences to Antigen SpecificityIan Setliff, Andrea R Shiakolas, Kelsey A Pilewski, et al.
Pageof 146